Insights on Clinical Trials

  1. How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials 4/17/2024

    Learn how to choose the right location — globally — for your next cell and gene therapy clinical trial.

  2. Cutting Red Tape: Direct Data Capture In Clinical Trials 4/12/2024

    Say goodbye to duplicate work in clinical trials. Discover how Direct Data Capture revolutionizes research, benefiting patients, sponsors, and sites while streamlining processes.

  3. The Business Case For EHR eSource In Clinical Trials 4/12/2024

    Examine how manual data collection challenges prompted the adoption of an eSource solution that streamlined data entry, saving time and costs, reducing errors, and accelerating a multicenter phase 2 trial.

  4. 2024: The Year of Development in Cell Therapy 4/10/2024

    We break down three trends driving development in cell therapy in 2024.

  5. 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies 4/9/2024

    Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.

  6. Insights Into The Clinical Trials Landscape Of CL 4/8/2024

    Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  7. Cystic Fibrosis: Global Clinical Trial Landscape (2024) 4/8/2024

    Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.

  8. Global Prevalence And Clinical Trials Landscape Of AML 4/8/2024

    Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  9. Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024) 4/8/2024

    Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.

  10. AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance 4/8/2024

    The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.